Literature DB >> 6972538

Cytotoxic T lymphocyte hybridomas that mediate specific tumor-cell lysis in vitro.

Y Kaufmann, G Berke, Z Eshhar.   

Abstract

Cytotoxic hybridomas were generated by polyethylene glycol-induced fusion of cytotoxic T lymphocytes (CTL) and BW5147 lymphoma cells. The CTL populations used for fusion were obtained from BALB/c (H-2d) mice primed with leukemia EL4 of C57BL/6 (H-2b) and restimulated either in vivo or in vitro. To circumvent possible CTL-mediated nonspecific lysis of BW5147 cells during fusion, the CTL were transiently inactivated by trypsin prior to fusion. Four cytolytically active hybridomas were obtained, cloned, and subcloned. Hybrid clones lysed all H-2b leukemic target cells tested but not lipopolysaccharide- or concavanalin A-stimulated C57BL/6 lymphoblasts or non-H2b target tumor cells. The mechanism of hybridoma-mediated killing of target cells in vitro appears to be similar to that of parental CTL, although some differences have been observed. The hybridomas appear to possess neither natural killing nor antibody-dependent cytolytic activity. Clones of hybrids propagated in culture for over 6 months without the addition of known external stimulus (i.e., independent of cell growth factor and antigen) exhibit specific lytic activity against H-2b tumor cells. Such autonomous hybridomas will provide a tool for studying the mechanism of CTL-mediated lysis and the nature of the CTL receptors.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6972538      PMCID: PMC319375          DOI: 10.1073/pnas.78.4.2502

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

1.  Functional characterization of membrane components of cytotoxic peritoneal exudate T lymphocytes. II. Trypsin sensitivity of the killer cell receptor.

Authors:  R F Todd
Journal:  Transplantation       Date:  1975-10       Impact factor: 4.939

2.  Continuous cultures of fused cells secreting antibody of predefined specificity.

Authors:  G Köhler; C Milstein
Journal:  Nature       Date:  1975-08-07       Impact factor: 49.962

3.  The significance of polyploidy for the evolution of mouse tumors; strains of the TA3 mammary adenocarcinoma with different ploidy.

Authors:  A LEVAN
Journal:  Exp Cell Res       Date:  1956-12       Impact factor: 3.905

4.  Antibodies to major histocompatibility antigens produced by hybrid cell lines.

Authors:  G Galfre; S C Howe; C Milstein; G W Butcher; J C Howard
Journal:  Nature       Date:  1977-04-07       Impact factor: 49.962

Review 5.  Mechanism of lymphocyte-mediated cytolysis. The LMC cycle and its role in transplantation immunity.

Authors:  G Berke; D B Amos
Journal:  Transplant Rev       Date:  1973

6.  Continuously proliferating T killer cells specific for H-2b targets: selection and characterization.

Authors:  G Dennert; M De Rose
Journal:  J Immunol       Date:  1976-06       Impact factor: 5.422

7.  Studies on the induction and expression of T cell-mediated immunity. IV. Non-overlapping populations of alloimmune cytotoxic lymphocytes with specificity for tumor-associated antigens and transplantation antigens.

Authors:  E Kedar; B Bonavida
Journal:  J Immunol       Date:  1975-11       Impact factor: 5.422

8.  The cloning of normal "mast" cells in tissue culture.

Authors:  D H Pluznik; L Sachs
Journal:  J Cell Physiol       Date:  1965-12       Impact factor: 6.384

9.  Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic acid allogeneic tumors. I. Distribution of reactivity and specificity.

Authors:  R B Herberman; M E Nunn; D H Lavrin
Journal:  Int J Cancer       Date:  1975-08-15       Impact factor: 7.396

10.  Generation of cytotoxic lymphocytes in mixed lymphocyte reactions. I. Specificity of the effector cells.

Authors:  J Forman; G Möller
Journal:  J Exp Med       Date:  1973-09-01       Impact factor: 14.307

View more
  16 in total

1.  Inducible functions in hybrids of a Lyt-2+ BW5147 transfectant and the 2C CTL line.

Authors:  J J Gu; P D Gottlieb
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

2.  Rearrangement and transcription of a T-cell receptor beta-chain gene in different T-cell subsets.

Authors:  S M Hedrick; R N Germain; M J Bevan; M Dorf; I Engel; P Fink; N Gascoigne; E Heber-Katz; J Kapp; Y Kaufmann
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

3.  T-cell antigen receptors with identical variable regions but different diversity and joining region gene segments have distinct specificities but cross-reactive idiotypes.

Authors:  F Rupp; J Brecher; M A Giedlin; T Mosmann; R M Zinkernagel; H Hengartner; R H Joho
Journal:  Proc Natl Acad Sci U S A       Date:  1987-01       Impact factor: 11.205

4.  B29: a member of the immunoglobulin gene superfamily exclusively expressed on beta-lineage cells.

Authors:  G G Hermanson; D Eisenberg; P W Kincade; R Wall
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

Review 5.  Neoplastic cells as targets of spontaneously cytotoxic lymphocytes: studies with natural killer-like cell lines.

Authors:  A E Lagarde
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

6.  Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity.

Authors:  G Gross; T Waks; Z Eshhar
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

7.  Anti-leucocyte function-associated antigen-1 antibodies inhibit T-cell activation following low-avidity and adhesion-independent interactions.

Authors:  G Gorochov; G Gross; T Waks; Z Eshhar
Journal:  Immunology       Date:  1993-08       Impact factor: 7.397

8.  Elimination of progressive mammary cancer by repeated administrations of chimeric antigen receptor-modified T cells.

Authors:  Anat Globerson-Levin; Tova Waks; Zelig Eshhar
Journal:  Mol Ther       Date:  2014-02-27       Impact factor: 11.454

9.  Mechanism of lymphocyte-mediated cytolysis: functional cytolytic T cells lacking perforin and granzymes.

Authors:  G Berke; D Rosen; D Ronen
Journal:  Immunology       Date:  1993-01       Impact factor: 7.397

10.  Human T cell hybridomas secreting immune interferon.

Authors:  J Le; J Vilcek; C Saxinger; W Prensky
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.